Tilray, a federally licensed cultivation company based in Nainamo, Canada, will begin exporting medical cannabis to New Zealand before the end of February.
It’s the latest overseas deal for Tilray, which is owned by Seattle-based private equity firm Privateer Holdings.
Both the Canadian and New Zealand governments have approved the MMJ exports, Tilray announced in a news release.
The company will export THC- and CBD-infused oils to Middlemore Hospital in New Zealand’s capital, Auckland. Tilray’s medical cannabis products will serve as another option for patients who use Sativex, an expensive, marijuana-based mouth spray, according to NZCity News.
New Zealand recently altered its medical cannabis laws to permit the Ministry of Health – instead of the department’s associate minister – to sign off on MMJ requests.
Tilray has been expanding its overseas sales in recent months. Earlier this month, Tilray announced it had secured an export agreement with a company in Chile. Tilray previously made deals to export medical cannabis to Australia and Croatia.